ALLMedicine™ Eczema Center

Jan 13th, 2021 - The role of hydrolyzed infant formulas in the prevention of asthma and allergies remains inconsistent. We tested whether extensively hydrolyzed casein formula compared to conventional cow's milk based formula prevented asthma, allergic rhinitis, o...

Jan 12th, 2021 - Psoriasis and atopic dermatitis (eczema) are both common immune-mediated inflammatory skin diseases associated with changes in skin's stratum corneum lipid structure and barrier functionality. The present study aimed to investigate healthy, eczema...

Jan 7th, 2021 - To explore young people's experiences of eczema self-management and interacting with health professionals. Secondary qualitative data analysis of data sets from two semistructured interview studies. Data were analysed using inductive thematic anal...

Jan 6th, 2021 - Children with atopic eczema are known to experience seasonal variations in disease severity, with winter being the season in which severity generally increases. There is a lack of knowledge about the subgroup of children that experiences increased...

Jan 4th, 2021 - The Harmonising Outcome Measures for Eczema (HOME) initiative has established a core outcome set of domains for atopic eczema (AE) clinical trials. Previous consensus meetings have agreed on preferred instruments for clinician-reported signs (Ecze...

Nov 4th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

Jun 24th, 2019 - Atopic dermatitis is a chronic, itchy skin condition that is very common in children but may occur at any age. It is also known as eczema and atopic eczema and was formerly known as Besnier prurigo. It is the most common form of dermatitis. Atopi...

Jun 3rd, 2019 - Eczema, also known as atopic dermatitis, is the most common form of dermatitis. Genetic as well as environmental factors are thought to play a part in the pathogenesis. Eczema is most commonly seen in children but can be seen in adults. People ...

May 29th, 2019 - Molluscum contagiosum (MC) is a self-limited infectious dermatosis, frequent in pediatric population, sexually active adults, and immunocompromised individuals. It is caused by molluscum contagiosum virus (MCV) which is a virus of the Poxviridae f...

Apr 25th, 2019 - Hand eczema is an inflammation of the skin of the hands that tends to run a chronic, relapsing course. This common condition is often associated with itch, social stigma, and impairment in employment. Many different interventions of unknown effect...

Jan 13th, 2021 - The role of hydrolyzed infant formulas in the prevention of asthma and allergies remains inconsistent. We tested whether extensively hydrolyzed casein formula compared to conventional cow's milk based formula prevented asthma, allergic rhinitis, o...

Jan 12th, 2021 - Psoriasis and atopic dermatitis (eczema) are both common immune-mediated inflammatory skin diseases associated with changes in skin's stratum corneum lipid structure and barrier functionality. The present study aimed to investigate healthy, eczema...

Jan 11th, 2021 - ■ for temporary relief of minor skin irritations, itching and rashes due to eczema, insect bites, poison ivy, poison oak, poison sumac, soaps, detergents, cosmetics, jewelry, and for external genital, feminine and anal itching. Other uses of this ...

Jan 10th, 2021 - USES: For the temporary relief of itching associated with minor, skin irritations and rashes due to eczema, insect bites, poison ivy/oak/sumac, soaps, detergents,cosmetics and jewelryItch Relief Cream

Jan 10th, 2021 - Temporarily protects and helps relieve minor skin irritations and itching due to eczema, rash and dermatitis.Skin protectant

Jan 7th, 2021 - Dupilumab treatment with concomitant topical corticosteroids provided rapid and sustained improvement in itch intensity and frequency in children aged 6-11 years with severe atopic dermatitis. Dr Gil Yosipovitch The findings come from a post hoc a...

Nov 22nd, 2020 - Gusacitinib, a novel oral inhibitor of multiple inflammatory pathways, achieved rapid and clinically meaningful improvement in corticosteroid-refractory moderate to severe chronic hand eczema in a phase 2b, randomized trial, Howard Sofen, MD, repo...

Nov 9th, 2020 - About 70% of patients on the oral selective Janus kinase 1 inhibitor abrocitinib for moderate to severe atopic dermatitis (AD) achieved high-efficacy responses without need for any supplemental topical therapies through 48 weeks of follow-up in th...

Nov 3rd, 2020 - Incessant pruritus (itchiness) is the central and most debilitating symptom of atopic dermatitis. According to guidelines from the American Academy of Dermatology (AAD), essential features that must be present for diagnosis include pruritus and ec...

Oct 29th, 2020 - Delgocitinib cream shows a dose-dependent response in easing chronic hand eczema, a common and difficult-to-treat disorder for which few other topical options are available, new international phase 2b research suggests. An investigational pan-janu...